Cliff Asness's SANA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 1.12 M shares of Sana Biotechnology, Inc. (SANA) worth $3.24 M, representing 0.00% of the portfolio. First purchased in 2023-Q4, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in SANA, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 783,217 shares. Largest reduction occurred in Q3 2025, reducing 174,581 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Sana Biotechnology (SANA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Sana Biotechnology (SANA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -10,045 | Reduce 0.89% | 1.12 M | $2.88 |
| Q4 2025 | -47,458 | Reduce 4.02% | 1.13 M | $4.07 |
| Q3 2025 | -174,581 | Reduce 12.87% | 1.18 M | $3.55 |
| Q2 2025 | +783,217 | Add 136.65% | 1.36 M | $2.73 |
| Q1 2025 | +190,483 | Add 49.78% | 573,146 | $1.68 |
| Q4 2024 | +311,255 | Add 435.88% | 382,663 | $1.63 |
| Q3 2024 | +71,408 | New Buy | 71,408 | $4.16 |
| Q2 2024 | -155,792 | Sold Out | 0 | $0.00 |
| Q1 2024 | +131,475 | Add 540.67% | 155,792 | $10.00 |
| Q4 2023 | +24,317 | New Buy | 24,317 | $4.08 |
Cliff Asness's Sana Biotechnology Investment FAQs
Cliff Asness first purchased Sana Biotechnology, Inc. (SANA) in Q4 2023, acquiring 24,317 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Sana Biotechnology, Inc. (SANA) for 10 quarters since Q4 2023.
Cliff Asness's largest addition to Sana Biotechnology, Inc. (SANA) was in Q2 2025, adding 1,356,363 shares worth $3.7 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 1,124,279 shares of Sana Biotechnology, Inc. (SANA), valued at approximately $3.24 M.
As of the Q1 2026 filing, Sana Biotechnology, Inc. (SANA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Sana Biotechnology, Inc. (SANA) was 1,356,363 shares, as reported at the end of Q2 2025.